CVIR - CardioVascular and Interventional Radiology

Startseite
österreich
Wien
CVIR - CardioVascular and Interventional Radiology

CardioVascular and Interventional Radiology (CVIR) is a peer-reviewed medical journal. It is an offi Founded in 1978 by Professors Herbert L.

It is the official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and is published by Springer Science+Business Media. Abrams and Eberhard Zeitler, CVIR is the oldest journal in the field and publishes peer-reviewed, original research work including laboratory and clinical investigations, technical notes, case reports, letters to the Editor, review articles and opinion papers from the fields of cardiac, vascular and interventional radiology. Over the years, the journal has become known for its cutting-edge research, quick manuscript processing times and high impact factor.

25/02/2026

Help us shape the future of CVIR - take the survey!

We warmly invite you to participate in the CVIR survey, where you can share your feedback and experiences as an author, reader or member of the community by Feb. 27.

As contributors to the journal, your work and experience either as an author, reader or reviewer play a key role in shaping CVIR’s success. CVIR relies on your feedback to learn what authors and readers value.

Tell us how we can support you better!

CVIR Survey 2026.

25/02/2026

Tumor Absorbed Dose Predicts Survival and Local Tumor Control in Colorectal Liver Metastases Treated with 90Y Radioembolization
https://link.springer.com/article/10.1007/s00270-025-04175-8

24/02/2026

Let's about it!

Our latest video features Prof. Andreas Mahnken who spoke about his paper "CIRSE Standards of Practice for the Provision of Emergency IR Care on a 24/7"

https://youtu.be/1Mxxh7LukLA

24/02/2026

Read now in CVIR 👇
Single-Session Percutaneous Cholangioscopy for High-Risk Patients with Biliary Stone Disease
https://link.springer.com/article/10.1007/s00270-025-04294-2

23/02/2026

Editor's Choice! 📖
Breast Cryoablation vs Surgery! Read this interesting cost-effectiveness analysis from the US indicating that in the management of early stage, unifocal small, lymph node-negative, US-visible breast cancer, cryo appears to be a more cost-effective option than breast-conserving surgery.
https://link.springer.com/article/10.1007/s00270-025-04269-3

22/02/2026

to 2024! 🔙
Blocking Arteries to Block Obesity
https://link.springer.com/article/10.1007/s00270-024-03774-1

22/02/2026

📖
Tunneled Peripherally Inserted Central Catheters and Bloodstream Infection: A Systematic Review and Meta-Analysis
https://link.springer.com/article/10.1007/s00270-025-04289-z

21/02/2026

Invited Commentary: “Road to Genicular Artery Embolization: Importance of the Anastomotic Network”
https://link.springer.com/article/10.1007/s00270-025-04181-w

20/02/2026

Read now in CVIR 📖
Commentary on “CT-Guided Percutaneous Cryoablation of Small Renal Masses: General Anesthesia Versus Conscious Sedation with Dexmedetomidine”
https://link.springer.com/article/10.1007/s00270-025-04206-4

19/02/2026

🔙
Irreversible Electroporation as a Valid Treatment Option for Hepatic Epithelioid Hemangioendothelioma: An International Multicenter Experience
https://link.springer.com/article/10.1007/s00270-024-03770-5

$Microarteriovenous Fistulas Causing Refractory Skin Ulcers: Feasibility and Safety of Transcatheter Embolizationhttps://...$

18/02/2026

Microarteriovenous Fistulas Causing Refractory Skin Ulcers: Feasibility and Safety of Transcatheter Embolization
https://link.springer.com/article/10.1007/s00270-025-04234-0

17/02/2026

Read now in CVIR 👇
CT Hepatic Arteriography for Improved Detection and Ablation of Occult HCC Nodules: A Retrospective Analysis
https://link.springer.com/article/10.1007/s00270-025-04276-4

Adresse

Neutorgasse 9
Wien
1010

Telefon

+431904200300

Webseite

http://www.cvironline.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von CVIR - CardioVascular and Interventional Radiology erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.